MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed May 12, 2017
Insider Transaction Report
Form 4
Drummond Daryl C
Head of Research
Transactions
- Exercise/Conversion
Common Stock
2017-05-12$2.69/sh+4,097$11,021→ 105,828 total(indirect: By Spouse) - Exercise/Conversion
Stock Option (right to buy)
2017-05-12−4,097→ 0 total(indirect: By Spouse)Exercise: $2.69Exp: 2017-07-03→ Common Stock (4,097 underlying) - Sale
Common Stock
2017-05-12$3.72/sh−4,097$15,241→ 101,731 total(indirect: By Spouse)
Footnotes (1)
- [F1]This option is fully vested.